Can a 8-Week online program ease distress in young cancer survivors?
NCT ID NCT06732375
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a behavioral program called Mindset Moments for young adults (ages 19-25) who have finished cancer treatment. The program includes weekly online group sessions and daily app activities focused on coping skills, mindfulness, and peer support. Researchers want to see if it is feasible and acceptable, and whether it helps reduce anxiety and depression. 40 participants will be followed for 8 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mindset Moments program (online group sessions with CBT, resilience training, mindfulness, peer support, and family conversations)
- What this could lead to
- If it works, this could point toward a practical, low-cost way to help young cancer survivors manage anxiety and depression after treatment.
- What could go wrong
- This is a very small pilot study (40 people) with no control group, so results may not be generalizable. It only measures short-term changes and cannot prove long-term benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 19-25 years of age * Prior AYA cancer diagnosis * Completed primary treatment for their cancer * Score of 3 or above on the Distress Thermometer at the time of recruitment Exclusion Criteria: * Individuals without legal capacity to give consent * Individuals who are not fluent in reading, writing, and speaking English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Duke Cancer Institute
RECRUITINGDurham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?